✦ LIBER ✦

408 INTERLEUKIN-6: A POTENTIAL BIOMARKER OF RESISTANCE TO MULTITARGETED RECEPTOR TYROSINE KINASE INHIBITORS IN CASTRATION-RESISTANT PROSTATE CANCER

✍ Scribed by Kutikov, Alexander; Makhov, Peter; Golovine, Konstantin; Canter, Daniel; Sirohi, Mohit; Street, Ryan; Uzzo, Robert G.; Kolenko, Vladimir M.

Book ID: 118483117
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 42 KB
Volume: 185
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.02.497

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-6: A Potential Biomarker of

Interleukin-6: A Potential Biomarker of Resistance to Multitargeted Receptor Tyrosine Kinase Inhibitors in Castration-resistant Prostate Cancer

✍ Alexander Kutikov; Peter Makhov; Konstantin Golovine; Daniel J. Canter; Mohit Si 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 702 KB

420 IN VIVO CASTRATION-RESISTANT ACCELER

420 IN VIVO CASTRATION-RESISTANT ACCELERATION OF PROSTATE CANCER INHIBITED BY A SMALL MOLECULE INHIBITOR OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR/INSULIN RECEPTOR TYROSINE KINASE

✍ Inoue, Takamitsu; Zakikhani, Mahvash; Mireuta, Matei; Blouin, Marie-José; Pollak 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 134 KB

A phase II study of lapatinib, a dual EG

A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer

✍ Whang, Young E.; Armstrong, Andrew J.; Rathmell, W. Kimryn; Godley, Paul A.; Kim 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 220 KB

744 ABSENCE OF ACTIVATING MUTATIONS OF E

744 ABSENCE OF ACTIVATING MUTATIONS OF EGFRAND HER-2/NEU AS PREDICTIVE MARKERS FOR RESPONSE TO TYROSINE-KINASE INHIBITORS IN PATIENTS WITH CASTRATION RESISTANT PROSTATE CANCER

✍ C.H. Ohlmann; G. Braun; V. Jung; M. Stöckle; U. Engelmann; A. Heidenreich 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Insulin-like growth factor-1 receptor (I

Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer

✍ Peled, Nir; Wynes, Murry W.; Ikeda, Norihiko; Ohira, Tatsuo; Yoshida, Koichi; Qi 📂 Article 📅 2013 🏛 Springer Netherlands 🌐 English ⚖ 583 KB

The fibroblast growth factor receptor si

The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer

✍ Scott A. Kono; Marianne E. Marshall; Kathryn E. Ware; Lynn E. Heasley 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 523 KB